Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Paramount Bed Holdings Co's annualizedNet Income for the quarter that ended in Sep. 2025 was $34.8 Mil. Paramount Bed Holdings Co's average total tangible assets for the quarter that ended in Sep. 2025 was $1,180.4 Mil. Therefore, Paramount Bed Holdings Co's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2025 was 2.95%.
The historical rank and industry rank for Paramount Bed Holdings Co's Return-on-Tangible-Asset or its related term are showing as below:
PBHDF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 1.37 Med: 5.71 Max: 7.19
Current: 1.37
During the past 13 years, Paramount Bed Holdings Co's highest Return-on-Tangible-Asset was 7.19%. The lowest was 1.37%. And the median was 5.71%.
PBHDF's Return-on-Tangible-Asset is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.62
vs PBHDF: 1.37
Paramount Bed Holdings Co (OTCPK:PBHDF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companyÂ’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companyÂ’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Paramount Bed Holdings Co Return-on-Tangible-Asset Related Terms
Paramount Bed Holdings Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Paramount Bed Holdings Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co Return-on-Tangible-Asset Chart
PBHDF vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Sep. 2025) net income data.
What does a Return-on-Tangible-Asset of 2.95% mean?
Paramount Bed Holdings Co (PBHDF) has a Return-on-Tangible-Asset of 2.95% as of Sep. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Paramount Bed Holdings Co and its competitors. This is 48% below median its historical median of 5.71. Over the past decade, Paramount Bed Holdings Co's Return-on-Tangible-Asset has ranged from 1.37 to 7.19.
Is Paramount Bed Holdings Co's Return-on-Tangible-Asset too high?
Paramount Bed Holdings Co's current Return-on-Tangible-Asset of 2.95% is 48% below median its 10-year median of 5.71. Over the past 10 years, this metric has ranged from a low of 1.37 to a high of 7.19. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.62. Paramount Bed Holdings Co's value of 2.95% is 375.8% above this industry median. Overall, Paramount Bed Holdings Co has a GF Scoreâ„¢ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's Return-on-Tangible-Asset compare to ISRG and BDX?
Paramount Bed Holdings Co's Return-on-Tangible-Asset of 2.95% can be compared against companies in the Medical Devices & Instruments industry. The industry median Return-on-Tangible-Asset is 0.62. Paramount Bed Holdings Co's value of 2.95% is 375.8% above this benchmark. Historically, Paramount Bed Holdings Co's own Return-on-Tangible-Asset has ranged from 1.37 to 7.19 over the past decade. While the company's 10-year median is 5.71 vs. the industry median of 0.62, Paramount Bed Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.62, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paramount Bed Holdings Co's current Return-on-Tangible-Asset of 2.95% is 375.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current Return-on-Tangible-Asset is 2.95%, which is 48% below median its own 10-year median of 5.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (PBHDF) has a current Return-on-Tangible-Asset of 2.95%. The stock's GF Value™ is $16.33, compared to a current price of $19.74 — trading 20.9% above its estimated fair value. The current Return-on-Tangible-Asset is 2.95%, which is 48% below median its 10-year median of 5.71 and 375.8% above the Medical Devices & Instruments industry median of 0.62. Paramount Bed Holdings Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Paramount Bed Holdings Co (PBHDF), the current Return-on-Tangible-Asset is 2.95% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (PBHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of $19.74 is trading 20.9% above its estimated GF Value™ of $16.33.
Key valuation signals for PBHDF:
Return-on-Tangible-Asset: 2.95% (48% below median its 10-year median of 5.71)
GF Value™: $16.33 vs. price of $19.74 (20.9% above fair value)
Industry Position: 375.8% above the Medical Devices & Instruments median
No single metric tells the full story. See the PBHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
90GF Score
Get the complete analysis for PBHDF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBHDF has been successfully added to your 
